Posts Tagged ‘paxlovid’

WP article

August 1, 2022

Biden covid case highlights confusing CDC guidance on ending isolation

https://www.washingtonpost.com/health/2022/08/01/biden-covid-cdc-guidance-isolation/

Fauci, Recovering From ‘Rebound’ of Covid, Praises Paxlovid – The New York Times

July 31, 2022

https://www.nytimes.com/2022/06/29/us/politics/fauci-paxlovid-covid.html

Paxlovid

July 31, 2022

https://www.yalemedicine.org/news/13-things-to-know-paxlovid-covid-19

Rebound

July 31, 2022

https://amp.cnn.com/cnn/2022/07/30/health/paxlovid-rebound-contagious-study-wellness/index.html

https://www.cidrap.umn.edu/news-perspective/2022/06/data-show-low-level-covid-rebound-paxlovid

Biden Tests Positive for Covid Again in ‘Rebound’ Case – The New York Times

July 31, 2022

https://www.nytimes.com/2022/07/30/us/politics/biden-covid-positive.html

Rebound COVID Is Just the Start of Paxlovid’s Mysteries – The Atlantic

July 31, 2022

https://www.theatlantic.com/health/archive/2022/05/paxlovid-covid-rebound-pfizer-clinical-trials/638438/

A tale of two antiviral targets — and the COVID-19 drugs that bind them

July 30, 2022

Found it interesting that while Paxlovid has had greater success against #COVID19, Molnupiravir (& Remdesivir) might have more promise for future pandemics

QT:{{”
Not all RdRp inhibitors work the same way. In most cases, including with remdesivir, viruses incorporate the drug into the elongating RNA, and this brings the elongation process to a halt. Molnupiravir’s mechanism is different: elongation doesn’t stop when the enzyme incorporates the drug into viral RNA. Instead, the virus reuses molnupiravir-containing RNAs as template strands, and incorporates the wrong bases into new viral RNA when it re-encounters molnupiravir. Mutations accumulate over cycles, leading to ‘error catastrophe’ and viral death.
“}}

https://www.nature.com/articles/d41573-021-00202-8

Biden’s COVID Is Back. Is Paxlovid to Blame? – The Atlantic

July 30, 2022

https://www.theatlantic.com/health/archive/2022/07/biden-paxlovid-covid-drug-rebound-infections/671009/